70. 広範脊柱管狭窄症 Spinal stenosis Clinical trials / Disease details
臨床試験数 : 95 / 薬物数 : 169 - (DrugBank : 61) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 90
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000012918 | 2014/04/01 | 01/03/2014 | Long-term efficacy and safety of Limaprost for the treatment of Lumbar Spinal Stenosis | Long-term efficacy and safety of Limaprost for the treatment of Lumbar Spinal Stenosis - Long-term efficacy of Limaprost for LSS | Lumbar Spinal Stenosis | Limaprost alfadex(15 micro g/day), 1yrs. | Kansai LSS Forum | NULL | Pending | 50years-old | 80years-old | Male and Female | 300 | Not selected | Japan |
| 2 | NCT01888536 (ClinicalTrials.gov) | February 2013 | 25/6/2013 | A Study to Evaluate Efficacy of ?Opast Tablet?for Neurologic Claudication in Patients With Lumbar Spinal Stenosis | A Randomized, Double-Blind, Comparative, Multi-Center, Phase ? Clinical Trial to Evaluate Efficacy of ?Opast Tablet?for Neurologic Claudication in Patients With Lumbar Spinal Stenosis | Neurologic Claudication in Patients With Lumbar Spinal Stenosis | Drug: Limaprost;Drug: Pregabalin;Drug: Placebo(for Pregabalin);Drug: Placebo(for Limaprost) | Yungjin Pharm. Co., Ltd. | NULL | Completed | 20 Years | 75 Years | Both | 182 | Phase 4 | Korea, Republic of |
| 3 | JPRN-UMIN000004825 | 2011/01/01 | 06/01/2011 | A randomized comparative study of Celecoxib and Limaprost alfadex on the patients with lumber spinal stenosis for the effectiveness for symptoms and QOL | A randomized comparative study of Celecoxib and Limaprost alfadex on the patients with lumber spinal stenosis for the effectiveness for symptoms and QOL - A randomized comparative study of medications for patients with lumber spinal stenosis | Lumbar spinal stenosis | 15ug/day Limaprost arfadex for 8 weeks 200mg/day Celecoxib for 8 weeks | University of Tsukuba, Course of life-style related disorders donated by JA Ibaraki Public Welfare Federation | Mito Kyodo Hospital | Complete: follow-up complete | 40years-old | 85years-old | Male and Female | 134 | Phase 3 | Japan |